Skip to content

Dive Deeper

Threat Status: Could a perfect storm of controversies reignite South Korean anti-Americanism?

TRENDING:
Donald Trump
Advertisement

Topic - Dendreon Corp.

Related Stories

Photos

In this undated photo provided by Dendreon Corp., an employee works on the company's prostate cancer drug Provenge at a plant in Morris Plains, N.J. Medicare officials said Wednesday, March 30, 2011 that the program will pay the $93,000 cost of the drug, an innovative therapy that typically gives men suffering from the disease an extra four months to live. (AP Photo/Dendreon Corp.) NO SALES